From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. Summary and Comment

CD4-Cell Decline Not Predicted by Viral Load

In untreated patients, baseline plasma viral load accounted for only 4% to 6% of CD4-cell loss.

Higher plasma viral load has been linked to increased risk for HIV disease progression in population studies, but the degree to which plasma viral load explains CD4-cell loss for individual patients is unknown. Now, in a multi-institutional study involving two cohorts of treatment-naive, chronically HIV-infected patients (total, 2801 patients), researchers have calculated the proportion of variability in CD4-cell–loss rate predicted by baseline plasma viral load. All participants had at least 6 months of follow-up, and at least one viral load and two CD4-cell–count measurements (with the initial measurements taken at baseline). Results obtained with the first cohort were validated by analysis of data from a second cohort — participants in the Multicenter AIDS Cohort Study.

For each cohort overall, increased baseline viral load was associated with accelerated CD4-cell decline. Despite that association, only a small proportion of CD4-cell–loss variability (4% to 6%) for individual subjects could be predicted by their baseline viral load. Use of multiple viral load measurements over time minimally increased the degree to which viral load predicted subsequent CD4-cell loss. Analyses restricted to subjects with high viral loads or accounting for the variability in an individual’s CD4-cell–count and viral load measurements over time did not substantially affect the results.

Comment: As noted by the authors, these results are at odds with the widely held notion that plasma viral load is the main determinant of the rate of CD4-cell loss for an individual patient. The findings suggest that baseline viral load, although very useful for assessing response to therapy, should play a limited role in determining when to start antiretroviral therapy. Other variables such as key genetic determinants, degree of T-cell activation, status of thymic function, and lymph tissue status can contribute in a complex, multifactorial manner to the immunologic and clinical sequelae of HIV infection. A better understanding of all the key determinants of CD4-cell loss might yield novel approaches to treatment that could positively affect the host-pathogen balance and add to the benefits seen with antiretroviral therapy.

— Keith Henry, MD

Dr. Henry wrote the editorial that accompanied this study.

Published in Journal Watch HIV/AIDS Clinical Care October 23, 2006

Citation(s):

Rodríguez B et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006 Sep 27; 296:1498-506.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.